Ina Schmidbauer

Collaborateur senior

Ina Schmidbauer

Ina specializes in regulatory advice in the healthcare sector. She advises medical care providers and investors in the outpatient sector on both medical professional and contract physician law and assists them in particular with the acquisition and establishment of medical care centers and medical practices and the regulatory licensing procedures.

Ina is an expert in regulatory compliance matters and supports clients in the development, design and regulatory implementation of innovative participation and cooperation models.

The focal points of her work are:

  • advising on the establishment and licensing of MVZs,
  • transactions in the healthcare sector, purchase and sale of medical practices
  • regulatory compliance matters
  • development and implementation of innovative participation and cooperation models between medical service providers
  • design of physician employee incentive models

Ina Schmidbauer is a lecturer in health law at Aalen University, regularly gives lectures on health law topics and has contributed to the update of Beck'sches Formularbuch Medizin- und Gesundheitsrecht.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Taylor Wessing advises NORD Holding and Zentrum Gesundheit on the acquisition of REALEYES Group

1 février 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Taylor Wessing advises NORD Holding and Zentrum Gesundheit on the acquisition of Klinik Flechsig

1 février 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

The Digital Act for the healthcare sector in Germany: New requirements for the use of cloud computing services in the healthcare sector

12 juin 2024
Briefing

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Femtech - what is it and what should manufacturers bear in mind from a regulatory perspective?

6 juin 2024
Briefing

par Dr. Angela Knierim

Cliquer ici pour en savoir plus